EDB Singapore and Agency for Science, Technology and Research

11 articles about EDB Singapore and Agency for Science, Technology and Research

• SCG Cell Therapy and A*STAR Launch Joint Labs With Collaboration Nearing S$30 Million to Advance iPSC Technology Towards Scalable GMP Manufacturing of Cellular Immunotherapies

  4/17/2024

  SCG Cell Therapy and the Agency for Science, Technology and Research announced the launch joint laboratories for cellular immunotherapies.

• Agilent and A*STAR’s SIFBI Sign Research Collaboration Agreement to Advance Singapore Agri-Food Industry

  1/27/2022

  Agilent Technologies Inc. recently signed a Research Collaboration Agreement with the Singapore Institute of Food and Biotechnology Innovation outlining their collaboration on developing food research knowledge advancement over the next two years.

• Waters to Help Accelerate Biologics Production Through Research Collaboration With Singapore’s Bioprocessing Technology Institute

  6/28/2021

  Waters Corporation announced an expansion of its joint work with the Bioprocessing Technology Institute, a research institute of Singapore's Agency for Science, Technology and Research.

• Aptorum Group Launches Infectious Disease Liquid Biopsy Subsidiary Start-up and Exclusively In-licensed from Singapore based Accelerate Technologies To Co-Develop Molecular Based Rapid Pathogen Diagnostics Technology To Track Pathogenic Genome

  9/29/2020

  Aptorum Group Limited announced its launch of Aptorum Innovations - an infectious disease liquid biopsy diagnostics subsidiary and its newly established exclusive in-licensing arrangements with Accelerate Technologies Pte Ltd

• Duke-NUS, GenScript and A*STAR launch first-in-the-world SARS-CoV-2 serology test to detect neutralising antibodies without need of containment facility or specimen

  5/15/2020

  As a first-in-the-world "rapid smart test kit", the cPass™ which can measure neutralising antibodies in an hour will be a huge boost to current COVID-19 investigations, from contact tracing, sero-prevalence survey, and assessment of herd immunity, longevity of protective immunity and efficacy of different vaccine candidates.

• Analysis Of Global Cancer Data Shines Light On Alternative Gene “Switches” In Tumours

  9/6/2019

  Novel genomics and computational methods reveal how gene “switches” impact survival rates of cancer patients, paving the way to targeted cancer treatments

• Self-Destructing Molecules Hold Key to Retard Superbug Development

  5/23/2019

  Singapore-based researchers have discovered a possible solution to impede the evolution of bacteria into superbugs that are resistant to drugs and therefore harder to kill.

• Molecules Swing Electrolytes across Membranes to Kill Cancer Cells

  5/23/2019

  Researchers from Singapore have designed the world’s first ‘molecular swing’ to transport electrolytes across cell membranes.

• A Faster And More Accurate Diagnostic Test For Mosquito-borne Diseases In The Works

  4/24/2019

  Singapore scientists are developing a single test that can detect and differentiate multiple mosquito-borne viruses and their types

• A*STAR and Soitec Launch Joint Program to Develop a New Layer Transfer Process for Advanced Packaging

  3/26/2019

  New cost competitive wafer-to-wafer layer transfer process delivers low power, increased yield and higher interconnection density and speed

• EDB Singapore and Agency for Science, Technology and Research Release: Singapore Reinforces Position as a Global Site for Pharma & Biotech

  6/18/2008